SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival

Liu, Q., Sasaki, T., Kozieradzki, I., Wakeham, A., Itie, A., Dumont, D. J., Penninger, J. M.·1999·Genes & Development

Cited by (340)

Items 101–200 of 340

  1. Microglial <i>INPP5D</i> limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease
    Castranio, Emilie L., Hasel, Philip, Haure‐Mirande, Jean‐Vianney, Ramirez Jimenez, Angie V., Hamilton, B. Wade, Kim, Rachel D., Glabe, Charles G., Wang, Minghui, Zhang, Bin, Gandy, Sam et al. · 2023 · Alzheimer's &amp; Dementia
  2. SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels
    Sylvie Giuriato, Xavier Pesesse, Stéphane Bodin, Takehiko Sasaki, Cécile Viala, Evelyne Marion, Josef Martin Penninger, Stéphane Schurmans, Christophé Erneux, Bernard Payrastre · 2003 · Biochemical Journal
  3. Pretreatment with phosphatase and tensin homolog deleted on chromosome 10 (PTEN) inhibitor SF1670 augments the efficacy of granulocyte transfusion in a clinically relevant mouse model
    Yitang Li, Amit Prasad, Yonghui Jia, Saurabh Ghosh Roy, Fabien Loison, Subhanjan Mondal, Paulina Kocjan, Leslie E. Silberstein, Sheng Ding, Hongbo Robert Luo · 2011 · Blood
  4. SHIP deficiency causes Crohn's disease-like ileitis
    William Garrow Kerr, Mi-Young Park, Monique Maubert, Robert W. Engelman · 2010 · Gut
  5. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3β signaling and leads to an increased transit time through the G1 phase of the cell cycle
    Stefan Horn, Elmar Endl, Boris Fehse, Markus M. Weck, Georg W. Mayr, Manfred Jücker · 2004 · Leukemia
  6. SHIP's C-terminus is essential for its hydrolysis of PIP3 and inhibition of mast cell degranulation
    Jacqueline E. Damen, Mark D. Ware, Janet Kalesnikoff, Michael R. Hughes, Gerald Krystal · 2001 · Blood
  7. Induced SHIP Deficiency Expands Myeloid Regulatory Cells and Abrogates Graft-versus-Host Disease
    Kim H.T. Paraiso, Tomar Ghansah, Amy Costello, Robert W. Engelman, William Garrow Kerr · 2007 · The Journal of Immunology
  8. Association of a transmembrane polymorphism of Fcγ receptor IIb (FCGR2B) with systemic lupus erythematosus in Taiwanese patients
    Ji-Yih Chen, Chin Man Wang, Chung‐Chun Ma, Shue‐Fen Luo, Jeffrey C. Edberg, Robert P. Kimberly, Jianming Wu · 2006 · Arthritis & Rheumatism
  9. Granulocyte-CSF links destructive inflammation and comorbidities in obstructive lung disease
    Evelyn Tsantikos, Maverick Lau, Cassandra M.N. Castelino, Mhairi J. Maxwell, Samantha L. Passey, Michelle J. Hansen, Narelle E. McGregor, Natalie A. Sims, Daniel Steinfort, Louis B. Irving et al. · 2018 · Journal of Clinical Investigation
  10. Src homology 2 domain–containing inositol 5-phosphatase 1 deficiency leads to a spontaneous allergic inflammation in the murine lung
    Sun-Young Oh, Tao Zheng, Monica L. Bailey, Dwayne L. Barber, John T. Schroeder, Yoon‐Keun Kim, Zhou Zhu · 2006 · Journal of Allergy and Clinical Immunology
  11. Akt–PDK1 Complex Mediates Epidermal Growth Factor-induced Membrane Protrusion through Ral Activation
    Hisayoshi Yoshizaki, Naoki Mochizuki, Yukiko Gotoh, Michiyuki Matsuda · 2006 · Molecular Biology of the Cell
  12. Downstream of Tyrosine Kinases-1 and Src Homology 2-Containing Inositol 5′-Phosphatase Are Required for Regulation of CD4+CD25+ T Cell Development
    Masaki Kashiwada, Giorgio Cattoretti, Lisa McKeag, Todd M. Rouse, Brian M. Showalter, Umaima Al‐Alem, Masaru Niki, Pier Paolo Pandolfi, Elizabeth H. Field, Paul B. Rothman · 2006 · The Journal of Immunology
  13. Leading-edge research: PtdIns(3,4,5)P3 and directed migration
    Jonathan Franca‐Koh, Yoichiro Kamimura, Peter N. Devreotes · 2007 · Nature Cell Biology
  14. Glycodelin-A Protein Interacts with Siglec-6 Protein to Suppress Trophoblast Invasiveness by Down-regulating Extracellular Signal-regulated Kinase (ERK)/c-Jun Signaling Pathway
    Kevin K.W. Lam, Philip C.N. Chiu, Cheuk‐Lun Lee, Ronald T.K. Pang, Carmen O.N. Leung, Hannu K. Koistinen, Markku T. Seppälä, Pak‐Chung Ho, William S.B. Yeung · 2011 · Journal of Biological Chemistry
  15. miR-155 promotes FLT3-ITD–induced myeloproliferative disease through inhibition of the interferon response
    Jared A. Wallace, Dominique Kagele, Anna M. Eiring, Carissa N. Kim, Ruozhen Hu, Marah C. Runtsch, Margaret Alexander, Thomas B. Huffaker, Soh-Hyun Lee, Ami B. Patel et al. · 2017 · Blood
  16. Regulation of the immune response by SHIP
    Michael March, Kodi S. Ravichandran · 2002 · Seminars in Immunology
  17. Phosphoinositide-3 kinase-PKB/Akt pathway activation is involved in fibroblast Rat-1 transformation by human T-cell leukemia virus type I tax
    Yan Liu, Yin Wang, Munekazu Yamakuchi, Satoko Masuda, Takeshi Tokioka, Shoji Yamaoka, Ikuro Maruyama, Isao Kitajima · 2001 · Oncogene
  18. Regulation of PtdIns(3,4,5)P3/Akt signalling by inositol polyphosphate 5-phosphatases
    Matthew J. Eramo, Christina Anne Mitchell · 2016 · Biochemical Society Transactions
  19. Frequency and amplitude control of cortical oscillations by phosphoinositide waves
    Ding Xiong, Shengping Xiao, Su Guo, Qingsong Lin, Fubito Nakatsu, Min Wu · 2016 · Nature Chemical Biology
  20. TEL-JAK2 Mediates Constitutive Activation of the Phosphatidylinositol 3′-Kinase/Protein Kinase B Signaling Pathway
    Melody H.-H. Nguyen, Jenny Ho, Bryan K. Beattie, Dwayne L. Barber · 2001 · Journal of Biological Chemistry
  21. Characterization of AQX ‐1125, a small‐molecule SHIP1 activator
    Grant R. Stenton, Lloyd F. Mackenzie, Patrick Tam, Jennifer L. Cross, Curtis Harwig, Jeffrey Raymond, Judy Toews, Joyce K. Y. Wu, Nancy Ogden, Thomas MacRury et al. · 2012 · British Journal of Pharmacology
  22. Hyperactivation of protein kinase B and ERK have discrete effects on survival, proliferation, and cytokine expression in Nf1-deficient myeloid cells
    Shane Donovan, Wendy L. See, Jeannette M. Bonifas, David Stokoe, Kevin Shannon · 2002 · Cancer Cell
  23. Stimulation of PI 3-kinase signaling via inhibition of the tumor suppressor phosphatase, PTEN
    C. Peter Downes, Sarah H. Ross, Hélène Maccario, Nevin M. Perera, Lindsay Davidson, Nicholas R. Leslie · 2006 · Advances in Enzyme Regulation
  24. Modeling the regulation of p53 activation by HIF‐1 upon hypoxia
    Ping Wang, Di Guan, Xiao‐Peng Zhang, Feng Liu, Wei Wang · 2019 · FEBS Letters
  25. Essential Role for the C-Terminal Noncatalytic Region of SHIP in FcγRIIB1-Mediated Inhibitory Signaling
    M. Javad Aman, Scott F. Walk, Michael March, Hua-Poo Su, Deborah Jeannean Carver, Kodi S. Ravichandran · 2000 · Molecular and Cellular Biology
  26. PTEN and Other PtdIns(3,4,5)P3 Lipid Phosphatases in Breast Cancer
    Mariah P. Csolle, Lisa M. Ooms, Antonella Papa, Christina Anne Mitchell · 2020 · International Journal of Molecular Sciences
  27. The inositol phosphatase SHIP-1 is negatively regulated by Fli-1 and its loss accelerates leukemogenesis
    Gurpreet Lakhanpal, Laura M. Vecchiarelli-Federico, Youjun Li, Jiuwei Cui, Monica L. Bailey, David Spaner, Daniel Dumont, Dwayne L. Barber, Yaacov Ben‐David · 2010 · Blood
  28. Deficiency of Src homology 2 domain–containing inositol 5-phosphatase 1 affects platelet responses and thrombus growth
    Sonia Séverin, Marie‐Pierre Gratacap, Nadège Lenain, Laetitia Alvarez, ETIENNE HOLLANDE, Josef Martin Penninger, Christian Gachet, Monique M Plantavid, Bernard Payrastre · 2007 · Journal of Clinical Investigation
  29. Negative feedback regulation of Rac in leukocytes from mice expressing a constitutively active phosphatidylinositol 3-kinase γ
    Carlotta Costa, Laura Barberis, Chiara Ambrogio, Andrea D. Manazza, Enrico Patrucco, Ornella Azzolino, Paul O. Neilsen, Elisa Ciraolo, Fiorella Altruda, Glenn D. Prestwich et al. · 2007 · Proceedings of the National Academy of Sciences
  30. Peroxisome Proliferator Activated Receptor α Ligands as Anticancer Drugs Targeting Mitochondrial Metabolism
    Maja Grabacka, Małgorzata Pierzchalska, Krzysztof Reiss · 2013 · Current Pharmaceutical Biotechnology
  31. SHIP inhibits Akt activation in B cells through regulation of Akt membrane localization
    Deborah Jeannean Carver, Mohammad Javad Aman, Kodi S. Ravichandran · 2000 · Blood
  32. SHIP1 Negatively Regulates Proliferation of Osteoclast Precursors via Akt-Dependent Alterations in D-Type Cyclins and p27
    Zhou, Ping, Kitaura, Hideki, Teitelbaum, Steven L, Krystal, Gerald, Ross, F Patrick, Takeshita, Sunao · 2006 · The Journal of Immunology
  33. Discovery and Development of Small Molecule SHIP Phosphatase Modulators
    Dennis R. Viernes, Lydia B. Choi, William Garrow Kerr, John D. Chisholm · 2013 · Medicinal Research Reviews
  34. SHIP2 multiple functions: A balance between a negative control of PtdIns(3,4,5)P 3 level, a positive control of PtdIns(3,4)P 2 production, and intrinsic docking properties
    Christophé Erneux, William’s Elong Edimo, Laurence Deneubourg, Isabelle Pirson · 2011 · Journal of Cellular Biochemistry
  35. Regulation of anaphylactic responses by phosphatidylinositol phosphate kinase type I α
    Junko Sasaki, Takehiko Sasaki, Masakazu Yamazaki, Kunie Matsuoka, Choji Taya, Hiroshi Shitara, Shunsuke Takasuga, Miki Nishio, Katsunori Mizuno, Teiji Wada et al. · 2005 · The Journal of Experimental Medicine
  36. Genetic Segregation of Inflammatory Lung Disease and Autoimmune Disease Severity in SHIP-1−/− Mice
    Mhairi J. Maxwell, Mubing Duan, Jane E. Armes, Gary P. Anderson, David Mathew Tarlinton, Margaret L. Hibbs · 2011 · The Journal of Immunology
  37. Involvement of phosphatidylinositol 3-kinase γ in neutrophil apoptosis
    Kuang‐Yao Yang, John J. Arcaroli, John Kupfner, Todd M. Pitts, Jong Sung Park, Derek Strasshiem, Reury-Perng Perng, Edward H Abraham · 2002 · Cellular Signalling
  38. Phosphoinositide lipids in primary cilia biology
    Sarah E. Conduit, Bart Vanhaesebroeck · 2020 · Biochemical Journal
  39. SHIP deficiency enhances HSC proliferation and survival but compromises homing and repopulation
    Caroline Desponts, Amy L. Hazen, Kim H.T. Paraiso, William Garrow Kerr · 2006 · Blood
  40. Mutually inhibitory Ras-PI(3,4)P 2 feedback loops mediate cell migration
    Xiaoguang Li, Marc Edwards, Kristen F. Swaney, Nilmani Singh, Sayak Bhattacharya, Jane A. Borleis, Long Yu, Pablo A. Iglesias, Jie Chen, Peter N. Devreotes · 2018 · Proceedings of the National Academy of Sciences
  41. Src Homology 2–containing 5-Inositol Phosphatase (SHIP) Suppresses an Early Stage of Lymphoid Cell Development through Elevated Interleukin-6 Production by Myeloid Cells in Bone Marrow
    Koji Nakamura, Taku Kouro, Paul W. Kincade, Alexander Malykhin, Kazuhiko Maeda, Kenneth Mark Coggeshall · 2004 · The Journal of Experimental Medicine
  42. The SH2-domain-containing inositol 5-phosphatase (SHIP) limits neutrophil motility and wound recruitment in zebrafish
    Pui‐Ying Lam, Sa Kan Yoo, Julie M. Green, Anna Huttenlocher · 2012 · Journal of Cell Science
  43. Granulocyte colony-stimulating factor and its receptor in normal hematophoietic cell development and myeloid disease
    G. J. M. van de Geijn, Lambertus H.J. Aarts, Stefan J. Erkeland, Joanna M. Prasher, L. P. Touw · 2003 · Reviews of physiology, biochemistry and pharmacology
  44. The SH2 Inositol 5-Phosphatase Ship1 Is Recruited in an SH2-dependent Manner to the Erythropoietin Receptor
    Jacqueline M. Mason, Bryan K. Beattie, Qiurong Liu, Daniel Dumont, Dwayne L. Barber · 2000 · Journal of Biological Chemistry
  45. Murine Pancreatic Adenocarcinoma Dampens SHIP-1 Expression and Alters MDSC Homeostasis and Function
    Shari Pilon‐Thomas, Nadine Nelson, Nasreen A. Vohra, Maya M. Jerald, Laura C. Pendleton, Károly Szekeres, Tomar Ghansah · 2011 · PLoS ONE
  46. The role of the PI3K-PKB signaling module in regulation of hematopoiesis
    Miranda Buitenhuis, Paul James Coffer · 2009 · Cell Cycle
  47. A Novel Oncogenic Role of Inositol Phosphatase SHIP2 in ER-Negative Breast Cancer Stem Cells: Involvement of JNK/Vimentin Activation
    Chiung-Hui Fu, Ruey‐Jen Lin, John Yu, Wen-Wei Chang, Guo-Shiou Liao, Wen‐Ying Chang, Ling-Ming Tseng, Yi-Fang Tsai, Jyh-Cherng Yu, Alice Lin-Tsing Yu · 2014 · Stem Cells
  48. Redox modification of Akt mediated by the dopaminergic neurotoxin MPTP, in mouse midbrain, leads to down‐regulation of pAkt
    Lalitha Durgadoss, Prakash Nidadavolu, Rupanagudi Khader Valli, Uzma Saeed, Mamata Mishra, Pankaj Seth, Vijayalakshmi Ravindranath · 2011 · The FASEB Journal
  49. Disruption of PKB signaling restores polarity to cells lacking tumor suppressor PTEN
    Ming‐Jer Tang, Miho Iijima, Yoichiro Kamimura, Lingfeng Chen, Long Yu, Peter N. Devreotes · 2010 · Molecular Biology of the Cell
  50. The Alzheimer's disease risk factor <i>INPP5D</i> restricts neuroprotective microglial responses in amyloid beta‐mediated pathology
    Samuels, Joshua D., Moore, Katelyn A., Ennerfelt, Hannah E., Johnson, Alexis M., Walsh, Adeline E., Price, Richard J., Lukens, John R. · 2023 · Alzheimer's &amp; Dementia
  51. PI3K keeps the balance between metabolism and cancer
    Laura Braccini, Elisa Ciraolo, Miriam Martini, Tracey Pirali, Giulia Germena, Katia Rolfo, Emilio Hirsch · 2012 · Advances in Biological Regulation
  52. SHIP-1 inhibits CD95/APO-1/Fas-induced apoptosis in primary T lymphocytes and T leukemic cells by promoting CD95 glycosylation independently of its phosphatase activity
    E Charlier, Claude Condé, J Zhang, Laurence Deneubourg, Emmanuel Di Valentin, Souad Rahmouni, Alain Chariot, Patrizia Agostinis, P-C Pang, Stuart M. Haslam et al. · 2010 · Leukemia
  53. Loss of SHIP and CIS Recruitment to the Granulocyte Colony-Stimulating Factor Receptor Contribute to Hyperproliferative Responses in Severe Congenital Neutropenia/Acute Myelogenous Leukemia
    Melissa G Hunter, Anand Jacob, Lynn C. O’Donnell, Amanda Agler, Lawrence J. Druhan, Kenneth Mark Coggeshall, Belinda Rene Avalos · 2004 · The Journal of Immunology
  54. Phosphatidylinositol‐3,4,5‐trisphosphate: Tool of choice for class I PI 3‐kinases
    Rachel S. Salamon, Jonathan Backer · 2013 · BioEssays
  55. Human Cytomegalovirus Induces an Atypical Activation of Akt To Stimulate the Survival of Short-Lived Monocytes
    Olesea Cojohari, Megan A. Peppenelli, Gary C. T. Chan · 2016 · Journal of Virology
  56. Regulation of FcγR-stimulated phagocytosis by the 72-kDa inositol polyphosphate 5-phosphatase: SHIP1, but not the 72-kDa 5-phosphatase, regulates complement receptor 3–mediated phagocytosis by differential recruitment of these 5-phosphatases to the phagocytic cup
    Horan, Kristy A., Watanabe, Ken-ichi, Kong, Anne M., Bailey, Charles G., Rasko, John E. J., Sasaki, Takehiko, Mitchell, Christina A. · 2007 · Blood
  57. Targeting the Phosphatidylinositol 3-Kinase/AKT Pathway for the Treatment of Multiple Myeloma
    Jingyu Zhu, M. Wang, B. Cao, Tingjun Hou, Xinliang Mao · 2014 · Current Medicinal Chemistry
  58. FLT3/ITD Mutation Signaling Includes Suppression of SHP-1
    Peili Chen, Mark J. Levis, Patrick Andrew Brown, Kyu-Tae Kim, Jeffrey Allebach, Donald Small · 2004 · Journal of Biological Chemistry
  59. The Src kinase Lyn is a negative regulator of mast cell proliferation
    Valerie Hernandez‐Hansen, Graham A. Mackay, Clifford A. Lowell, Bridget Smith Wilson, Janet M. Oliver · 2003 · Journal of Leukocyte Biology
  60. Enzymatic and non-enzymatic activities of SHIP-1 in signal transduction and cancer
    Claude Condé, Geoffrey Gloire, Jacques G. Piette · 2011 · Biochemical Pharmacology
  61. Phosphatidylinositol Kinases and Phosphatases in Entamoeba histolytica
    Kumiko Nakada‐Tsukui, Natsuki Watanabe, Tomohiko Maehama, Tomoyoshi Nozaki · 2019 · Frontiers in Cellular and Infection Microbiology
  62. Role of SHIP1 in cancer and mucosal inflammation
    Sandra Regina Muchinechi Fernandes, Sonia Iyer, William Garrow Kerr · 2013 · Annals of the New York Academy of Sciences
  63. Evidence for a positive role of SHIP in the BCR-ABL–mediated transformation of primitive murine hematopoietic cells and in human chronic myeloid leukemia
    Xiaoyan Jiang, Matthew Stuible, Yves Chalandon, Andra Li, Wing Yiu Chan, Wolfgang Eisterer, Gerald Krystal, Allen C. Eaves, Connie J. Eaves · 2003 · Blood
  64. How do inhibitory phosphatases work?
    Kenneth Mark Coggeshall, Koji Nakamura, Hyewon Phee · 2002 · Molecular Immunology
  65. Mechanisms of resistance to EGFR inhibitors in head and neck cancer
    Jonathan B. Cooper, Ezra E.W. Cohen · 2009 · Head & Neck
  66. SHIP Is Required for Dendritic Cell Maturation
    Frann Antignano, Mariko Ibaraki, Connie Kim, Jens Rüschmann, Angela Zhang, Cheryl D. Helgason, Gerald Krystal · 2010 · The Journal of Immunology
  67. Anemia, thrombocytopenia, leukocytosis, extramedullary hematopoiesis, and impaired progenitor function in Pten+/-SHIP-/- mice: a novel model of myelodysplasia
    Jennifer L. Moody, Lixin Xu, Cheryl D. Helgason, Frank Robert Jirik · 2004 · Blood
  68. Phosphatidylinositol 3,4,5‐trisphosphate modulation in SHIP2‐deficient mouse embryonic fibroblasts
    Daniel Bléro, Jing Zhang, Xavier Pesesse, Bernard Payrastre, Jacques E. Dumont, Stéphane Schurmans, Christophé Erneux · 2005 · FEBS Journal
  69. PSTPIP2, a Protein Associated with Autoinflammatory Disease, Interacts with Inhibitory Enzymes SHIP1 and Csk
    Ales Drobek, Jarmila Sekeresova Kralova, Tereza Skopcova, Marketa Kucova, Petr Novák, Pavla Angelisová, Pavel Otáhal, Meritxell Alberich-Jordà, Tomáš Brdička · 2015 · The Journal of Immunology
  70. Distinct inactivation of PI3K signalling by PTEN and 5-phosphatases
    Nicholas R. Leslie, Miles J. Dixon, Martijn Schenning, Alex Gray, Ian H. Batty · 2011 · Advances in Biological Regulation
  71. Therapeutic potential of phosphoinositide 3-kinase inhibitors
    Beth E. Drees, Gordon Brent Mills, Christian Rommel, Glenn D. Prestwich · 2004 · Expert Opinion on Therapeutic Patents
  72. Interstitial leukocyte migration in vivo
    Pui‐Ying Lam, Anna Huttenlocher · 2013 · Current Opinion in Cell Biology
  73. Advancements in immune tolerance
    Ping‐Ying Pan, Junko J. Ozao, Zuping Zhou, Shu‐Hsia Chen · 2007 · Advanced Drug Delivery Reviews
  74. The expression pattern of the ITIM-bearing lectin CLECSF6 in neutrophils suggests a key role in the control of inflammation
    Manon Richard, Patricia Veilleux, Michèle Rouleau, Robert Paquin, André D. Beaulieu · 2002 · Journal of Leukocyte Biology
  75. Impaired T-cell survival promotes mucosal inflammatory disease in SHIP1-deficient mice
    Mi Young Park, Neetu Srivastava, Raki Sudan, Dennis R. Viernes, John D. Chisholm, Robert W. Engelman, William Garrow Kerr · 2014 · Mucosal Immunology
  76. FcγRIIB signals inhibit BLyS signaling and BCR-mediated BLyS receptor up-regulation
    Jenni E. Crowley, Jason E. Stadanlick, John C. Cambier, Michael P. Cancro · 2008 · Blood
  77. Fanconi anemia type C–deficient hematopoietic stem/progenitor cells exhibit aberrant cell cycle control
    Xiaxin Li, Paul Artur Plett, Yanzhu Yang, Ping Hong, Brian W. Freie, Edward F. Srour, Christie M. Orschell, D. Wade Clapp, Laura S. Haneline · 2003 · Blood
  78. Phosphatidylinositol 3′ Kinase Signaling in Mammary Tumorigenesis
    Michael P. Scheid, James Robert Woodgett · 2001 · Journal of Mammary Gland Biology and Neoplasia
  79. CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation
    Zheng Wang, Mohit M. Hulsurkar, Lijuan Zhuo, Jinbang Xu, Han Yang, Samira Naderinezhad, Lin Wang, Guoliang Zhang, Nanping Ai, Linna Li et al. · 2021 · Neoplasia
  80. IP3 3-kinase B controls hematopoietic stem cell homeostasis and prevents lethal hematopoietic failure in mice
    Sabine Siegemund, Stéphanie Rigaud, Claire Conche, Blake Broaten, Lana Schaffer, Luise Westernberg, Steven Robert Head, Karsten Sauer · 2015 · Blood
  81. Leukemia-associated mutations in SHIP1 inhibit its enzymatic activity, interaction with the GM-CSF receptor and Grb2, and its ability to inactivate PI3K/AKT signaling
    Brauer, Helena, Strauss, Julia, Wegner, Wiebke, Müller-Tidow, Carsten, Horstmann, Martin, Jücker, Manfred · 2012 · Cellular Signalling
  82. Activation of SHIP via a small molecule agonist kills multiple myeloma cells
    Michael Kennah, Tien Yin Yau, Matt Nodwell, Gerald Krystal, Raymond J. Andersen, Christopher John Ong, Alice Mui · 2009 · Experimental Hematology
  83. Non-T Cell Activation Linker Promotes Mast Cell Survival by Dampening the Recruitment of SHIP1 by Linker for Activation of T Cells
    Karine Roget, Marie Malissen, Odile Malbec, Bernard MALISSEN, Marc Daëron · 2008 · The Journal of Immunology
  84. The PI3K pathway drives the maturation of mast cells via microphthalmia transcription factor
    Peilin Ma, Raghuveer Singh Mali, Veerendra Munugalavadla, Subha Krishnan, Baskar Ramdas, Emily Kristen Sims, Holly Martin, Joydeep Ghosh, Shuo Li, Rebecca J. Chan et al. · 2011 · Blood
  85. Positive Regulation of Interleukin-4-mediated Proliferation by the SH2-containing Inositol-5′-phosphatase
    Cosmas C. Giallourakis, Masaki Kashiwada, Ping‐Ying Pan, Nika N. Danial, Hong Jiang, John C. Cambier, Kenneth Mark Coggeshall, Paul B. Rothman · 2000 · Journal of Biological Chemistry
  86. The Janus Kinase Inhibitor, JAB/SOCS-1, Is an Interferon-γ Inducible Gene and Determines the Sensitivity to Interferons
    Hiroshi Sakamoto, Ichiko Kinjyo, Akihiko Yoshimura · 2000 · Leukemia & lymphoma/Leukemia and lymphoma
  87. Molecular control of PtdIns(3,4,5)P3 signaling in neutrophils
    Hongbo Robert Luo, Subhanjan Mondal · 2015 · EMBO Reports
  88. Lineage extrinsic and intrinsic control of immunoregulatory cell numbers by SHIP
    Michelle M. Collazo, Kim H.T. Paraiso, Mi‐Young Park, Amy L. Hazen, William Garrow Kerr · 2012 · European Journal of Immunology
  89. Genetic reduction of class IA PI-3 kinase activity alters fetal hematopoiesis and competitive repopulating ability of hematopoietic stem cells in vivo
    Laura S. Haneline, Hilary A. White, Feng‐Chun Yang, Chen Shi, Christie M. Orschell, Reuben Kapur, David A. Ingram · 2005 · Blood
  90. Mouse Models of Myelodysplastic Syndromes
    Sarah H. Beachy, Peter D. Aplan · 2010 · Hematology/Oncology Clinics of North America
  91. The tumor suppressor SHIP1 colocalizes in nucleolar cavities with p53 and components of PML nuclear bodies
    Patrick A. H. Ehm, Marcus M. Nalaskowski, Torsten Wundenberg, Manfred Jücker · 2015 · Nucleus
  92. PIP3 pathway in regulatory T cells and autoimmunity
    Masaki Kashiwada, Ping Lü, Paul B. Rothman · 2007 · Immunologic Research
  93. Genetic Interdependence of Lyn and Negative Regulators of B Cell Receptor Signaling in Autoimmune Disease Development
    Evelyn Tsantikos, Mhairi J. Maxwell, Nicole Kountouri, Kenneth W. Harder, David Mathew Tarlinton, Margaret L. Hibbs · 2012 · The Journal of Immunology
  94. Scratching the surface: signaling and routing dynamics of the CSF3 receptor
    Ivo P. Touw · 2012 · Frontiers in bioscience
  95. Lyn-Dependent Signaling Regulates the Innate Immune Response by Controlling Dendritic Cell Activation of NK Cells
    Danielle L. Krebs, Manreet K. Chehal, Alexander Sio, Nicholas D. Huntington, Mei Lin Da, Pascal Ziltener, Melissa Inglese, Nicole Kountouri, John J. Priatel, Jessica E. C. Jones et al. · 2012 · The Journal of Immunology
  96. Cloning of the Genomic Locus of Mouse SH2 Containing Inositol 5-Phosphatase (SHIP) and a Novel 110-kDa Splice Isoform, SHIPδ
    Ingrid Wolf, David M Lucas, Paul A. Algate, Larry R. Rohrschneider · 2000 · Genomics
  97. Regulation of apoptosis in mast cells
    Adrian Martin Piliponsky, Francesca Levi‐Schaffer · 2000 · APOPTOSIS
  98. pp60c-src associates with the SH2-containing inositol-5-phosphatase SHIP1 and is involved in its tyrosine phosphorylation downstream of αIIbβ3 integrin in human platelets
    Sylvie Giuriato, Stéphane Bodin, Christophé Erneux, Rüdiger Woscholski, Monique M Plantavid, Hugues Chap, Bernard Payrastre · 2000 · Biochemical Journal
  99. Characterization of a Myeloid Tyrosine Phosphatase, Lyp, and Its Role in the Bcr-Abl Signal Transduction Pathway
    Wenwen Chien, Nicola Tidow, Elizabeth A. Williamson, Lee‐Yung Shih, Utz O. Krug, Arminja Nadine Kettenbach, Anthony C. Fermin, Chaim M. Roifman, Harold Phillip Koeffler · 2003 · Journal of Biological Chemistry
  100. Src Homology 2 (SH2)-Containing 5′-Inositol Phosphatase Localizes to Podosomes, and the SH2 Domain Is Implicated in the Attenuation of Bone Resorption in Osteoclasts
    Keiichiro Yogo, Megumi Mizutamari, Kazuta Mishima, Hiromi Takenouchi, Norihiro Ishida‐Kitagawa, Takehiko Sasaki, Tatsuo Takeya · 2006 · Endocrinology